| Metabolic modeling of single Th17 cells reveals regulators of autoimmunity A Wagner, C Wang, J Fessler, D DeTomaso, J Avila-Pacheco, J Kaminski, ... Cell 184 (16), 4168-4185. e21, 2021 | 243 | 2021 |
| The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity A Schnell, L Bod, A Madi, VK Kuchroo Cell research 30 (4), 285-299, 2020 | 184 | 2020 |
| Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma LJ Wrobel, L Bod, R Lengagne, M Kato, A Prévost-Blondel, FA Le Gal Oncotarget 7 (47), 77825, 2016 | 80 | 2016 |
| Checkpoint receptor TIGIT expressed on Tim-1+ B cells regulates tissue inflammation S Xiao, L Bod, N Pochet, SB Kota, D Hu, A Madi, J Kilpatrick, J Shi, A Ho, ... Cell reports 32 (2), 2020 | 42 | 2020 |
| IL-4–Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation L Bod, L Douguet, C Auffray, R Lengagne, F Bekkat, E Rondeau, ... The Journal of Immunology 200 (3), 1027-1038, 2018 | 37 | 2018 |
| Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma L Douguet, L Bod, R Lengagne, L Labarthe, M Kato, MF Avril, ... Oncoimmunology 5 (8), e1208878, 2016 | 37 | 2016 |
| B-cell-specific checkpoint molecules that regulate anti-tumour immunity L Bod, YC Kye, J Shi, E Torlai Triglia, A Schnell, J Fessler, SM Ostrowski, ... Nature 619 (7969), 348-356, 2023 | 35 | 2023 |
| IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma L Bod, R Lengagne, L Wrobel, JP Ramspott, M Kato, MF Avril, ... Oncoimmunology 6 (3), e1278331, 2017 | 35 | 2017 |
| Emerging role of IL-4–induced gene 1 as a prognostic biomarker affecting the local T-cell response in human cutaneous melanoma JP Ramspott, F Bekkat, L Bod, M Favier, B Terris, A Salomon, L Djerroudi, ... Journal of Investigative Dermatology 138 (12), 2625-2634, 2018 | 28 | 2018 |
| T follicular regulatory cell–derived fibrinogen-like protein 2 regulates production of autoantibodies and induction of systemic autoimmunity W Sungnak, A Wagner, MS Kowalczyk, L Bod, YC Kye, PT Sage, ... The Journal of Immunology 205 (12), 3247-3262, 2020 | 19 | 2020 |
| Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma L Douguet, L Bod, L Labarthe, R Lengagne, M Kato, I Couillin, ... Oncoimmunology 7 (9), e1484979, 2018 | 15 | 2018 |
| Nitric oxide synthase 2 improves proliferation and glycolysis of peripheral γδ T cells L Douguet, J Cherfils-Vicini, L Bod, R Lengagne, E Gilson, ... PLoS One 11 (11), e0165639, 2016 | 13 | 2016 |
| Metabolic and epigenomic regulation of th17/treg balance by the polyamine pathway C Wang, A Wagner, J Fessler, J Avila-Pacheco, J Karminski, P Thakore, ... BioRxiv, 2020.01. 23.911966, 2020 | 5 | 2020 |
| Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling P Cadinu, KN Sivanathan, A Misra, RJ Xu, D Mangani, E Yang, JM Rone, ... Cell 187 (8), 2010-2028. e30, 2024 | 1 | 2024 |
| Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation A Schnell, L Huang, BML Regan, V Singh, D Vonficht, A Bollhagen, ... Nature Immunology 24 (11), 1908-1920, 2023 | 1 | 2023 |
| Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy OY Revach, AM Cicerchia, O Shorer, B Petrova, S Anderson, J Park, ... bioRxiv, 2024 | | 2024 |
| Temporal single cell profiling identifies B-cell specific checkpoint molecules that regulate anti-tumor immunity L Bod CANCER IMMUNOLOGY RESEARCH 11 (12), 2023 | | 2023 |
| Abstract PR04: Temporal single cell profiling identifies B-cell specific checkpoint molecules that regulate anti-tumor immunity L Bod Cancer Immunology Research 11 (12_Supplement), PR04-PR04, 2023 | | 2023 |
| 561 Targeting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy OY Revach, A Cicerchia, M Sade-Feldman, S Anderson, B Petrova, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Targeting regulatory b cells and their regulators for cancer immunotherapy VK Kuchroo, S Xiao, BOD Lloyd US Patent App. 17/438,545, 2022 | | 2022 |
Vijay Kumar Kuchroovkuchroo@evergrande.hms.harvard.eduVerified email at evergrande.hms.harvard.edu
